Oyugi Julius O, Vouriot Françoise C M, Alimonti Judie, Wayne Stephen, Luo Ma, Land Allison M, Ao Zhujun, Yao Xiaojian, Sekaly Rafick P, Elliott Lawrence J, Simonsen J Neil, Ball T Blake, Jaoko Walter, Kimani Joshua, Plummer Francis A, Fowke Keith R
Department of Medical Microbiology, University of Manitoba, Winnipeg, MB, Canada.
J Infect Dis. 2009 May 1;199(9):1327-34. doi: 10.1086/597616.
It has been predicted that CD4 C868T, a novel CD4 single-nucleotide polymorphism (SNP) that has been found to be highly prevalent among Africans, changes the tertiary structure of CD4, which may alter susceptibility to human immunodeficiency virus (HIV) infection.
Participants were from a Kenyan cohort and included 87 uninfected and 277 HIV-1-infected individuals. DNA sequencing was used to determine CD4 genotype. A2.01 cells expressing similar levels of either wild-type CD4 or CD4-Trp240 as well as peripheral blood mononuclear cells from uninfected donors were infected with HIV-1(IIIB) or a Kenyan primary HIV-1 isolate. HIV-1 p24 enzyme-linked immunosorbent assay was used to determine the outcome of infection.
CD4 C868T was found to be significantly more prevalent among HIV-1-infected participants than among HIV-1-uninfected participants (P = .002), and C868T was associated with an increased incidence of HIV-1 infection as well (P = .005, log-rank test; P = .009, Wilcoxon test), with an odds ratio of 2.49 (P = .009). Both in vitro and ex vivo models demonstrated a significant association between CD4 C868T and susceptibility to HIV-1 infection (P < .001 and P = .003, respectively).
Overall, the present study found a strong correlation between CD4 C868T and increased susceptibility to HIV-1 infection. Given the high prevalence of both HIV infection and CD4 C868T in African populations, the effect of this SNP on the epidemic in Africa could be dramatic.
据预测,CD4 C868T是一种新发现的CD4单核苷酸多态性(SNP),在非洲人群中高度流行,它会改变CD4的三级结构,这可能会改变人类免疫缺陷病毒(HIV)感染的易感性。
参与者来自肯尼亚队列,包括87名未感染个体和277名HIV-1感染个体。采用DNA测序确定CD4基因型。用HIV-1(IIIB)或肯尼亚原发性HIV-1分离株感染表达相似水平野生型CD4或CD4-Trp240的A2.01细胞以及未感染供体的外周血单个核细胞。采用HIV-1 p24酶联免疫吸附试验确定感染结果。
发现CD4 C868T在HIV-1感染参与者中的流行率显著高于HIV-1未感染参与者(P = .002),并且C868T也与HIV-1感染发生率增加相关(P = .005,对数秩检验;P = .009,Wilcoxon检验),优势比为2.49(P = .009)。体外和离体模型均显示CD4 C868T与HIV-1感染易感性之间存在显著关联(分别为P < .001和P = .003)。
总体而言,本研究发现CD4 C868T与HIV-1感染易感性增加之间存在密切相关性。鉴于非洲人群中HIV感染和CD4 C868T的高流行率,该SNP对非洲疫情的影响可能很大。